These awards are for up to three years funding at $250K/year for studies to address critical challenges in Myelodysplastic Syndromes.

EvansMDS is conducting this competitive grant program to identify and fund research into the etiology, pathogenesis, and treatment of MDS that is collaborative, transformative, and of high impact. Priority will be given to projects that directly examine key features of MDS rather than general concepts in leukemia, hematopoiesis, aging or immunology. 

Read complete details about this grant (pdf)